Prospective Comparison of Hepatocellular Carcinoma Behavior and Survival of Patients who Did or Did not Receive HCV Direct-Acting Antivirals

BACKGROUND & AIMS: The safety and efficacy of hepatitis C (HCV) direct-acting antivirals (DAAs) have been established in several real-world trials; however, some reports have claimed an association between DAAs and hepatocellular carcinoma (HCC) occurrence or aggressive behavior. We aimed to pro...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Kassas, Mohamed, Sayed, Hamdy, Omran, Dalia, Eldahrouty, Ali Hussein, Elbaz, Tamer, Kamal, Enas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162632/
https://www.ncbi.nlm.nih.gov/pubmed/36853310
http://dx.doi.org/10.31557/APJCP.2023.24.2.597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162632/
https://www.ncbi.nlm.nih.gov/pubmed/36853310
http://dx.doi.org/10.31557/APJCP.2023.24.2.597

Ejemplares similares